Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-177809

Xenbase Image ID: 177809


Figure S4: trpc1 knock-down impairs the expression of the early neural gene, sox2. Embryos were co-injected at the 8-cell stage into a single dorsal animal blastomere with nuclear β-galactosidase mRNA (150 pg) and either (A,B) the standard control-MO (CMO; 17 ng) or (C-F) TRPC1-MO1 (17 ng). Embryos were then fixed at stage 14 for subsequent whole-mount in situ hybridization for sox2; see black arrows. The side of the embryo injected with MO was confirmed by reaction of β-galactosidase with Red-Gal, as shown by the red labelling on each embryo; see red arrows. (A-B) Images from 2 different embryos injected with CMO showing similar levels of sox2 expression on the left and right side of the embryos. (C-F) Images from 4 different embryos injected with TRPC1-MO1 showing that the expression of sox2 was reduced (see black arrows) on the injected side. Scale bar 500 µm

Image published in: Néant I et al. (2019)

© The Author(s) 2019. This image is reproduced with permission of the journal and the copyright holder. This is an open-access article distributed under the terms of the Creative Commons Attribution license

Larger Image
Printer Friendly View

Return to previous page